ESMO (European Society for Medical Oncology) shared on LinkedIn:
“For ESMO members: Breaking Science in Gastrointestinal Cancers:
Kohei Shitara talks about the Perioperative pembrolizumab plus chemotherapy in locally-advanced gastric/GEJ cancer.
Don’t miss this video and others from the series on OncologyPRO.”
Source: ESMO/LinkedIn